Investors interested in the Genomics and Synthetic Biology theme should consider these stocks: Twist Bioscience Corporation, ...

There is a problem with genomics. As the Human Genome Initiative progresses, it is becoming increasingly clear that the behavior of gene products is difficult or impossible to predict from gene ...

10x Genomics (NASDAQ:TXG) announced on Monday that its ATAC-Seq patents were found valid and infringed in its patent ...

Thermo Fisher's Vulcan Automated Lab combines advanced electron microscopy with artificial intelligence and robotics to optimize semiconductor manufacturing. Thermo Fisher Scientific has announced the ...

The lab will offer arrayed CRISPR screening for chronic disease through collaborations with researchers from across the U.K.

PLEASANTON, Calif., March 3, 2025 /PRNewswire/ — 10x Genomics (Nasdaq: TXG), a leader in single-cell and spatial biology, today provided an update on its patent litigation with Parse Biosciences.

"This development further validates the strength of our broad patent portfolio, which helps protect and preserve the world-class innovation engine at 10x," said Eric S. Whitaker, Chief Legal ...

10x Genomics (TXG) provided an update on its patent litigation with Parse Biosciences. Through a consent agreement entered on February 25, in the United States District Court for the District of ...

PLEASANTON, Calif., March 3, 2025 /PRNewswire/ -- 10x Genomics (Nasdaq: TXG), a leader in single-cell and spatial biology, today provided an update on its patent litigation with Parse Biosciences.